Abstract:Mitochondrial dysfunction is a central contributor to the development of β‐cell failure and Type 2 Diabetes (T2D). Succinate dehydrogenase subunit B (SDHB) is a key component of the Succinate Dehydrogenase (SDH) protein complex that strongly impacts mitochondrial function via 1) oxidation of succinate to fumarate in the TCA cycle and 2) electron transfer in the electron transport chain as Complex II. Loss of SDH activity has been observed in diabetic β‐cells (humans and rodents); however, the relevance of this observation to diabetes pathogenesis remains poorly understood. Consistent with prior work, we found reduced SDHB expression in the pancreatic islets of human diabetics. To investigate the links between mitochondrial dysfunction, β‐cell failure and diabetes, we generated mice with a β‐cell‐specific knockout of SDHB (SDHB β KO ). We found that SDHB β KO mice develop early onset diabetes. At 5 weeks, prediabetic SDHB β KO mice demonstrate mildly elevated glucose levels with low insulin levels and normal insulin sensitivity. These in vivo findings were confirmed by a reduction in glucose‐stimulated insulin secretion in SDHB β KO islets. Furthermore, glucose‐induced β‐cell replication was impaired in SDHB β KO mice; consistent with impaired adaptive β‐cell expansion. Given the prominent role of glucose metabolism in controlling β‐cell insulin secretion and replication, we assessed the mitochondrial bioenergetics by Seahorse Assay and found that basal and glucose‐stimulated respiration were significantly reduced in SDHB β KO islets. Notably, loss of SDH is expected to increase succinate accumulation and promote protein succinylation, a recently described bulky post‐translational modification. Indeed, SDHB β KO islets demonstrated a dramatic increase in succinate levels (16‐fold) and protein succinylation (6‐fold), providing a potential mechanism for global mitochondrial dysfunction. Accordingly, expression of the desuccinylation enzyme, Sirt5, was increased in SDHB β KO islets. Metabolomics by mass spectrometry and transcriptomics by high‐throughput RNA sequencing revealed significantly altered mitochondrial metabolism. Finally, protein succinylation levels were increased in islets of diabetic db/db mice indicating lysine‐succinylation may be characteristic of diabetes. Taken together, these results demonstrate a surprisingly necessary role for the SDH complex in β‐cell function and introduce a pathogenic mechanism of diabetes based upon β‐cell metabolic dysfunction. Support or Funding Information Stanford Diabetes Research Center (SRDC) Pilot & Feasibility Grants Program (P30DK116074), Endocrinology Training grant (T32DK007217) and Child Health Research Institute at Stanford (UL1TR001085)

The deacylase sirtuin 5 reduces malonylation in nonmitochondrial metabolic pathways in diabetic kidney disease

Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology

SIRT5 Deacylates Metabolism-Related Proteins and Attenuates Hepatic Steatosis in Ob/ob Mice.

Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications

SIRT5 deacylates metabolism-related proteins and attenuates hepatic steatosis in ob/ob miceResearch in context

SIRT1–SIRT7 in Diabetic Kidney Disease: Biological Functions and Molecular Mechanisms

Sirtuin and metabolic kidney disease

General Control of Amino Acid Synthesis 5-Like 1-Mediated Acetylation of Manganese Superoxide Dismutase Regulates Oxidative Stress in Diabetic Kidney Disease

SIRT5-related lysine demalonylation of GSTP1 contributes to cardiomyocyte pyroptosis suppression in diabetic cardiomyopathy

Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation

387-P: Novel Mitochondrial Complex I Modulator Reduces Diabetes-Associated Expression of Inflammation and Fibrosis Markers in Human Proximal Tubular Epithelial Cells

Distinctive Roles of Sirtuins on Diabetes, Protective or Detrimental?

Key enzyme in charge of ketone reabsorption of renal tubular SMCT1 may be a new target in diabetic kidney disease

Mitochondrial Dysfunction Promotes Diabetes via A Previously Unrecognized Mechanism: Protein Succinylation

Mitochondrial metabolic reprogramming in diabetic kidney disease

Lysine demethylase KDM5B down-regulates SIRT3-mediated mitochondrial glucose and lipid metabolism in diabetic neuropathy

Abstract P3187: Deletion Of SARM1 NAD Hydrolase Ameliorates Diabetic Cardiomyopathy By Regulating Mitochondrial Metabolism And Mitophagy

Unraveling the nexus of NAD+ metabolism and diabetic kidney disease: insights from murine models and human data

SIRT6's function in controlling the metabolism of lipids and glucose in diabetic nephropathy

SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA.

Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease